Related Experiment Videos
The hedamycin locus implicates a novel aromatic PKS priming mechanism
Tsion Bililign1, Chang-Gu Hyun, Jessica S Williams
1Laboratory for Biosynthetic Chemistry, Pharmaceutical Sciences Division, School of Pharmacy, University of Wisconsin-Madison, 777 Highland Avenue, Madison, Wisconsin 53705, USA.
Chemistry & Biology
|July 24, 2004
Summary
Researchers cloned the hedamycin biosynthetic gene cluster from Streptomyces griseoruber. This study reveals a novel iterative type I polyketide synthase (PKS) system priming a type II PKS for pluramycin antibiotic production.
Area of Science:
- Microbiology
- Molecular Biology
- Biochemistry
Background:
- Pluramycin-type antibiotics, like hedamycin, exhibit antitumor properties.
- Understanding the biosynthesis of these complex molecules is crucial for drug development.
Purpose of the Study:
- To clone and analyze the biosynthetic gene cluster of the pluramycin-type antitumor antibiotic hedamycin.
- To elucidate the polyketide synthase (PKS) system involved in hedamycin biosynthesis.
Main Methods:
- Cloning of the hedamycin biosynthetic gene cluster from Streptomyces griseoruber.
- Sequence analysis of the 45.6 kb gene cluster.
- Gene disruption experiments to confirm gene function.
Main Results:
- Identification of unique features including a fabH homolog (KSIII), acyltransferase (AT) gene, type I PKS genes, and C-glycosyltransferase genes.
- The study is the first to report the cloning of a pluramycin biosynthetic gene cluster.
- Gene disruption confirmed the essential roles of both type I and type II PKS genes in hedamycin biosynthesis.
Conclusions:
- Hedamycin biosynthesis involves an iterative type I PKS system for a novel starter unit that primes a type II PKS system.
- A second catalytic ketosynthase (KSIII) appears to regulate this unusual priming step.
- This research provides significant insights into the complex PKS machinery underlying pluramycin antibiotic production.